Lobbying client
MILLENNIUM PHARMACEUTICALS INC
biopharmaceutical company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.
Filings
48
Filed by
3
Reported in-house
—
Reported by firms
$1,614,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2007 to 2012
Filings
48 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination 4th Quarter 2012
|
PODESTA GROUP, INC. | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2012
|
PODESTA GROUP, INC. | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2012
|
PODESTA GROUP, INC. | $50,000 reported |
|
1st Quarter - Report 1st Quarter 2012
|
PODESTA GROUP, INC. | $50,000 reported |
|
4th Quarter - Report 4th Quarter 2011
|
PODESTA GROUP, INC. | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2011
|
PODESTA GROUP, INC. | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2011
|
PODESTA GROUP, INC. | $50,000 reported |
|
1st Quarter - Report 1st Quarter 2011
|
PODESTA GROUP, INC. | $50,000 reported |
|
4th Quarter - Report 4th Quarter 2010
|
PODESTA GROUP, INC. | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2010
|
PODESTA GROUP, INC. | $50,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| PODESTA GROUP, INC. | 22 | $1,180,000 |
| OGR | 10 | $410,000 |
| LNE GROUP | 9 | $24,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 28 |
| Medicare/Medicaid | MMM | 27 |
| Budget/Appropriations | BUD | 25 |
| Pharmacy | PHA | 22 |
| Copyright/Patent/Trademark | CPT | 17 |
| Medical/Disease Research/Clinical Labs | MED | 5 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| S. 717 | 111th | 11 |
| H.R. 3590 | 111th | 9 |
| S. 2029 | 110th | 9 |
| H.Con.Res. 112 | 112th | 8 |
| H.R. 4872 | 111th | 8 |
| H.R. 3162 | 110th | 8 |
| S. 610 | 111th | 7 |
| S. 515 | 111th | 7 |
| H.R. 1260 | 111th | 7 |
| H.R. 2608 | 112th | 6 |
| S. 1213 | 111th | 6 |
| H.R. 2502 | 111th | 6 |
| S. 1110 | 111th | 6 |
| S. 301 | 111th | 6 |
| H.R. 3081 | 111th | 6 |
| S. 1505 | 110th | 6 |
| S. 623 | 110th | 6 |
| S. 1695 | 110th | 6 |
| S. 1145 | 110th | 6 |
| H.R. 1956 | 110th | 6 |
| H.R. 1038 | 110th | 6 |
| S. 3 | 110th | 6 |
| H.R. 1908 | 110th | 6 |
| S. 365 | 112th | 5 |
| H.R. 3200 | 111th | 5 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.